相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Concerns About Provenge Simmer as CMS Ponders Coverage
Merrill Goozner
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Listening to Provenge - What a Costly Cancer Treatment Says about Future Medicare Policy
James D. Chambers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Approval of Provenge Seen As First Step for Cancer Treatment Vaccines
Vicki Brower
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
When is Cancer Care Cost-Effective? A Systematic Overview of Cost-Utility Analyses in Oncology
Dan Greenberg et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
New Therapies for Castration-Resistant Prostate Cancer.
Dan L. Longo
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Pharmaceutical risk-sharing agreements
Joseph P. Cook et al.
PHARMACOECONOMICS (2008)
Coverage options for promising technologies: Medicare's 'coverage with evidence development'
Sean R. Tunis et al.
HEALTH AFFAIRS (2006)
分享论文
